Skip to content

Shares (Basic) at other companies

Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
316M+1.6%
Viatris logo
ViatrisVTRS
1.2B-3.1%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
28.7M-6.4%
ALN
Alnylam PharmaceuticalsALNY
132.9M+2.5%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
132.4M-4.7%
Amgen logo
AmgenAMGN
540M+0.4%

Other financials

Income statement

See full
Revenue$237.5M+20.5%
Gross profit$143.9M+16.0%
Operating income$38.9M+48.5%
Net income$29.5M+88.1%
EPS (diluted)$1.28+85.5%

Balance sheet

See full
Cash & equivalents$311.2M+108%
Total debt$305.3M-3.5%
Total equity$562.3M+34.3%
Total assets$1.4B+10.0%

Cash flow

See full
Operating cash flow$58.4M+66.8%
CapEx$6.1M+146%
Free cash flow$52.3M+60.8%

Valuation

See full
Market cap$1.89B+18.3%
Enterprise value$1.88B+5.8%
P/E20.5×
P/S-0.3×

Profitability

See full
Gross margin60.8%+1.5pp
Operating margin13.4%
Net margin10%+8.1pp
FCF margin20.7%+10.8pp

Returns & leverage

See full
Return on equity18.8%+15.6pp
Debt / equity0.5×-0.2×
Current ratio3.1×+0.5×

Where this comes from

Reported directly by ANI Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about ANI Pharmaceuticals's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is ANI Pharmaceuticals's shares (basic)?
ANI Pharmaceuticals (ANIP) reported shares (basic) of 20.9M in Q1 2026.
How has ANI Pharmaceuticals's shares (basic) changed year-over-year?
ANI Pharmaceuticals's shares (basic) increased by 6.7% year-over-year, from 19.6M to 20.9M.
What is the long-term trend for ANI Pharmaceuticals's shares (basic)?
Over 4 years (2021 to 2025), ANI Pharmaceuticals's shares (basic) has grown at a 13.0% compound annual growth rate (CAGR), from 48.8M to 79.6M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.